Determining Risk Factors for Successful PPI Weaning

Mount Carmel Health System

Status

Terminated

Conditions

Gastroesophageal Reflux

Treatments

Behavioral: Lifestyle Modifications

Study type

Interventional

Funder types

Other

Identifiers

NCT03226054

160809-6

Details and patient eligibility

About

Gastroesophageal Reflux Disease ("GERD") can happen when stomach acid flows backward into your esophagus (tube from the mouth to the stomach), causing symptoms such as heartburn. Proton pump inhibitors (called "PPIs") are a type of medication that reduce acid in the stomach and are used to reduce the discomfort from GERD. Treatment for GERD with PPIs is recommended to last up to eight weeks; however, many people take them for longer periods. Some people are placed on PPIs (particularly in the hospital) to prevent ulcers and inflammation of the stomach, but they do not need to be on the medication long term. Previous research studies have shown that there are some risks with taking PPIs for a long time. These risks include the inability of your body to absorb some vitamins and minerals, certain infections such as pneumonia or the digestive tract infection called "C. diff," and possibly bone fractures. Therefore, it is desirable to stop taking a PPI when possible.

The purpose of this study is to use a standard approach to help patients stop taking PPIs by adopting lifestyle habits known to reduce the symptoms of GERD while they slowly reduce their PPI dose. All medications used for this study are approved by the U.S. Food and Drug Administration ("FDA"). You are being asked to take part in this study because you have been taking a PPI for longer than the recommended time, and have either a diagnosis of GERD, gastritis, or an unclear indication for being on a PPI. About 100 patients from the Mount Carmel St. Ann's Family Medicine practice will participate in this research.

Enrollment

5 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

> 18 years old
Male or female
PPI on home medication reconciliation
GERD that is symptom controlled (per questionnaire), OR
Gastritis that is symptom controlled (per questionnaire), OR
An unclear indication for PPI use but free of GERD/gastritis/ulcer symptoms (includes patients on GI prophylaxis from the hospital and continued medication)
Desire or willingness to be off of PPI chronically
On PPI chronically (> 2 months or 8 weeks, can be intermittent use)
Initial PPI dose cannot exceed more than the equivalent of Omeprazole 40mg PO BID
Comprehend English well (per provider's discretion; to understand questionnaires, instructions, etc.)

Exclusion criteria

On PPI for fewer than 2 months
Co-morbid diagnosis of Peptic Ulcer Disease, H.pylori infection, Barrett's esophagus, malignancy, Inflammatory Bowel Disease
Diagnosis of moderate to severe renal impairment (defined as CrCl <50 mL/min; reasoning due to caution of H2RB on renal failure)
Diagnosis of prolonged QT interval with renal impairment (reasoning due to H2RB with concomitant renal failure may increase QT interval if not renally dosed)
True allergy to Proton Pump Inhibitor and / or H2 Receptor Blocker
Patients with frequent cardiac angina symptoms (decreasing the dose of PPI may cause rebound GERD and the patient may think they are having a heart attack)
Pregnant women, fetuses, neonates or fetal material
Females of reproductive potential at time of research that are not on a form on birth control (OCPs, tubal ligation, etc) or lactating
Adults with decisional impairment
Prisoners
Patients with uncontrolled Psychological illness